Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Rinsch"


4 mentions found


Urolithin A supplement company Timeline has investments from both Nestlé and L'Oréal. This year, the conversation quickly turned to the supplement du jour, the compound that has drawn investment from both Nestlé and L'Oréal: Urolithin A. Starting in 2008, Rinch's supplement company, Amazentis, funded over a dozen studies on urolithin A, including some relatively large, placebo-controlled trials in people — a rarity in supplement research. Urolithin A has also captured the attention of longevity researchers, who are typically more skeptical about products promising to make you young again. Timeline was on the agenda at this year's ARDD, an annual longevity research conference held in Copenhagen in August.
Persons: , There's, Urolithin, Hilary Brueck, Chris Rinsch, Rinsch, Johan Auwerx, Amazentis, Auwerx, He's, Mark Hyman, Dave Asprey, Gwyneth Paltrow's, Will Cole, Dominic Denk, Denk, wouldn't, Timeline's, Andrea Maier, it's, Maier Organizations: Service, VC, Business, Frankfurt University Hospital, National University of Singapore Locations: Gstaad, Swiss, skincare, urolithin, Davos, Copenhagen, Germany, Switzerland, Nestlé
An arbitrator ruled in Netflix’s favor in a high-profile dispute between the streaming giant and the Hollywood director Carl Erik Rinsch over a science-fiction series that never aired, awarding the company nearly $9 million in damages. Mr. Rinsch had sold Netflix the television show, “Conquest,” near the height of the streaming boom in 2018, but he never delivered any episodes. Netflix had to write off the $55 million it had spent on the project — a fiasco that became a symbol of the era of profligate spending that Hollywood studios are trying to put behind them as they focus on increasing profits rather than simply adding subscribers. Netflix canceled the development of “Conquest” in early 2021 after Mr. Rinsch’s behavior turned erratic. In texts and emails to Netflix executives, he claimed to have discovered Covid-19’s secret transmission mechanism and told his wife, a producer on the show, that he could predict earthquakes and lightning strikes.
Persons: Carl Erik Rinsch, Rinsch Organizations: Netflix, Hollywood Locations: Netflix’s,
A movie director used Netflix funds to trade options and cryptocurrencies, The New York Times said. "47 Ronin" director Carl Erik Rinsch bet on Gilead Sciences and dogecoin, and against the S&P 500. He lost $6 million on options, but a winning bet on dogecoin boosted his balance to $27 million. NEW LOOK Sign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. AdvertisementA Hollywood director took millions of dollars of production funding from Netflix and used it to trade stock options and cryptocurrencies, The New York Times said on Wednesday.
Persons: Carl Erik Rinsch, dogecoin, , Here's, Carl Erik Rinsch's, Rinsch's, Rinsch, Gilead, Dogecoin, Constantin, Rinsch didn't Organizations: The New York Times, Gilead Sciences, Service, Netflix Locations: The, Gilead
He had directed only one movie, “47 Ronin.” It was a commercial and critical dud, and Mr. Rinsch’s tussles with its producers had raised eyebrows, even in an industry where such conflicts are the norm. Amid the feeding frenzy, the project that Mr. Rinsch was pitching — a science-fiction series about artificial humans — became a hot property. After a competitive auction, Mr. Rinsch and his representatives reached an informal eight-figure agreement with Amazon. The project with Mr. Rinsch has turned into a costly fiasco, a microcosm of the era of profligate spending that Hollywood studios now are scrambling to end. Netflix burned more than $55 million on Mr. Rinsch’s show and gave him near-total budgetary and creative latitude but never received a single finished episode.
Persons: Carl Erik Rinsch, Rinsch’s, Rinsch, Cindy Holland Organizations: Disney, Apple, Amazon, Netflix, Hollywood Locations: Hollywood
Total: 4